Early 6 months usage of single anTiplAtelet OR anTicoAgulant followed by single antiplatelet after transcatheter aortic valve replacement: protocol for a multicentre, open-label, randomised controlled clinical trial.
Xiangming HuHaiyan XuCan WangYang WangYan WangDaxin ZhouQifeng ZhuKai XuJian YangHaibo ZhangNan JiangJunjie ZhangZhenfei FangGuo-Sheng FuYingqiang GuoYi LiMoyang WangDejing FengGuannan NiuErli ZhangYang ChenYunqing YeYongjian WuPublished in: BMJ open (2023)
NCT05375474.
Keyphrases
- transcatheter aortic valve replacement
- clinical trial
- open label
- study protocol
- aortic valve
- aortic stenosis
- randomized controlled trial
- phase ii
- double blind
- atrial fibrillation
- phase iii
- venous thromboembolism
- phase ii study
- squamous cell carcinoma
- radiation therapy
- cross sectional
- coronary artery disease
- ejection fraction
- left ventricular
- placebo controlled